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AKI

:   acute kidney injury

AKI‐MELD

:   acute kidney injury--model for end‐stage liver disease

AUROC

:   area under the receiver operating characteristic curve

CAKI

:   critically ill patients with cirrhosis and acute kidney injury

CI

:   confidence interval

Cr~48hours~/Cr

:   ratio of creatinine in 48 hours to creatinine at admission

Del‐Cr‐MELD

:   deleted‐creatinine‐model for end‐stage liver disease

HR

:   hazard ratio

ICU

:   intensive care unit

INR

:   international normalized ratio

MELD

:   model for end‐stage liver disease

Introduction {#hep41076-sec-0001}
============

Acute kidney injury (AKI) is one of the most common complications in critically ill patients with cirrhosis and is linked to increased morbidity and mortality.[1](#hep41076-bib-0001){ref-type="ref"}, [2](#hep41076-bib-0002){ref-type="ref"}, [3](#hep41076-bib-0003){ref-type="ref"} The progression of AKI is often associated with the onset of progressive multiorgan dysfunctions or failure, which occurs in up to approximately 20% of critically ill patients with cirrhosis.[2](#hep41076-bib-0002){ref-type="ref"}, [4](#hep41076-bib-0004){ref-type="ref"}

The model for end‐stage liver disease (MELD) score, a well‐known and useful tool for patients with cirrhosis, is calculated based on serum creatinine, the international normalized ratio (INR), and serum bilirubin.[5](#hep41076-bib-0005){ref-type="ref"} Although the MELD score has resulted in successfully predicting prognosis, creatinine as a suboptimal marker for renal function has poor specificity and sensitivity for the early diagnosis of critically ill patients with cirrhosis and acute kidney injury (CAKI).[6](#hep41076-bib-0006){ref-type="ref"}, [7](#hep41076-bib-0007){ref-type="ref"}, [8](#hep41076-bib-0008){ref-type="ref"}

Further studies have enhanced the debate on the actual role of creatinine in the existing MELD score.[8](#hep41076-bib-0008){ref-type="ref"}, [9](#hep41076-bib-0009){ref-type="ref"} Romano et al.[9](#hep41076-bib-0009){ref-type="ref"} suggested that serum creatinine had no impact in predicting AKI after orthotopic liver transplantation despite its importance in the MELD score calculation. Sharma[8](#hep41076-bib-0008){ref-type="ref"} analyzed data from 38,899 liver transplantation candidates from the Scientific Registry of Transplant Recipients and updated the MELD score formula with a lower relative weight for serum creatinine and a higher relative weight for bilirubin. Moreover, serum creatinine concentration remains questionable as an indicator for the severity of renal dysfunction of CAKI. The stable high creatinine values of patients with chronic renal insufficiency may be considered to have an equal mortality risk for CAKI with normal renal function. Our first aim in this study was to determine whether creatinine has a substantial discriminating potential for predicting mortality in CAKI.

We hypothesized that a modified MELD score incorporating new AKI‐related variables can provide an improvement on its prognostic accuracy. Although the diagnosis of AKI has been a source of significant controversy in nephrology, the Acute Kidney Injury Network criteria are based on an absolute serum creatinine change in a 48‐hour period and possess adequate prognostic accuracy for both established and early detection of AKI in hospitalized patients.[10](#hep41076-bib-0010){ref-type="ref"}, [11](#hep41076-bib-0011){ref-type="ref"}, [12](#hep41076-bib-0012){ref-type="ref"}, [13](#hep41076-bib-0013){ref-type="ref"} The risk, injury, failure, loss, and end‐stage kidney disease classification provides three grades of severity for AKI and is also based on serum changes in creatinine in the short‐term from the baseline condition.[14](#hep41076-bib-0014){ref-type="ref"}, [15](#hep41076-bib-0015){ref-type="ref"} Recent studies have demonstrated that even minor changes in serum creatinine are an indication of an acute deterioration of renal function.[16](#hep41076-bib-0016){ref-type="ref"}, [17](#hep41076-bib-0017){ref-type="ref"}, [18](#hep41076-bib-0018){ref-type="ref"} For this reason, changes in serum creatinine may be a more suitable predictor for mortality in CAKI. Therefore, our second aim was to develop a new model incorporating the ratio of creatinine in 48 hours to creatinine at admission (Cr~48hours~/Cr) rather than creatinine for CAKI to predict mortality.

Patients and Methods {#hep41076-sec-0002}
====================

SUBJECTS {#hep41076-sec-0003}
--------

A longitudinal study was performed using the Multiparameter Intelligent Monitoring in Intensive Care database, version 3.0. This a freely accessible, large‐scale, critical care database and a collection of around 50,000 medical records from patients admitted to the Intensive Care Unit (ICU) at Beth Israel Deaconess Medical Center (Boston, MA) from June 2001 to October 2012.

A total of 651 CAKI in the ICU were recruited. Inclusion criteria included individuals with a primary diagnosis of cirrhosis and who presented with symptoms of AKI (increased creatinine and/or oliguria). Excluded from our study were individuals with pregnancy, toxicity conditions, autoimmune diseases, past or current hepatocellular carcinoma, other causes that might lead to AKI, or other identifiable causes of serious diseases in other organ systems.

DEFINITION {#hep41076-sec-0004}
----------

The diagnosis of cirrhosis was made either by histology if liver biopsy showed evidence or by compatible imaging findings and clinical manifestations (e.g., ascites, esophageal varices, sepsis, gastrointestinal hemorrhage, progressive jaundice, hepatic encephalopathy, or spontaneous bacterial peritonitis).

AKI is defined as any of the following: increase in serum creatinine equal to or greater than 0.3 mg/dL within 48 hours; increase in serum creatinine to 1.5 times baseline; urine output less than 0.5 mL/kg/hour for 6 hours.[13](#hep41076-bib-0013){ref-type="ref"} For patients without an available creatinine value before admission, we followed the recommendations of the International Club of Ascites and used the first creatinine value measured during hospitalization as the baseline creatinine.[19](#hep41076-bib-0019){ref-type="ref"}, [20](#hep41076-bib-0020){ref-type="ref"}

DATA COLLECTION {#hep41076-sec-0005}
---------------

For all study patients, data contained clinical and laboratory parameters within the first 24 hours after admission to the ICU. Clinical parameters included heart rate, respiration, temperature, and systolic and diastolic blood pressure, while laboratory parameters included glucose, white blood cell count, platelet count, sodium, potassium, blood urea nitrogen, partial pressure of arterial oxygen, partial pressure of arterial carbon dioxide, fraction of inspired oxygen, bicarbonate, creatinine, lactate, INR, and bilirubin. The following relevant variables were included: age, sex, height, weight, ethnicity, vasopressin used, and the diagnosis of cirrhosis.

OUTCOME {#hep41076-sec-0006}
-------

All patients were followed up for at least 1 year. The primary endpoints were defined at 30‐day, 90‐day, and 1‐year all‐cause mortality. Our permission to access the database was approved after completion of the National Institutes of Health web‐based training course "Protecting Human Research Participants" (our certification number, 1605699).

MELD SCORING SYSTEMS {#hep41076-sec-0007}
--------------------

MELD score, MELD‐Na score, and Updated MELD score (described in more detail under Statistical Analysis) were computed using the aforementioned indicators as follows: MELD: R = 9.57 × log~e~(creatinine \[mg/dL\]) + 3.78 × log~e~(bilirubin \[mg/dL\]) + 11.2 × log~e~ (INR) + 6.43.[5](#hep41076-bib-0005){ref-type="ref"}MELD‐Na: R = MELD + 1.59 × (135 -- Na \[mmol/L\]).[21](#hep41076-bib-0021){ref-type="ref"}Updated MELD: R = 1.27 × log~e~(1 + creatinine \[mg/dL\]) + 0.94 × log~e~(1 + bilirubin \[mg/dL\]) + 1.66 × log~e~(1 + INR).[8](#hep41076-bib-0008){ref-type="ref"}

STATISTICAL ANALYSIS {#hep41076-sec-0008}
--------------------

Statistical analysis was performed using SPSS version 23.0 (IBM, Armonk, NY) and MedCalc version 12.7 (MedCalc Software, Ostend, Belgium). Continuous and categorical data were presented at baseline using mean ± SD and frequencies (percentage), respectively. The Student *t* test was performed for comparisons of continuous baseline characteristics, and the chi‐square test was performed for categorical values. Cox\'s proportional hazards regression was used to calculate hazard ratios (HRs) for relative risk of mortality.

To evaluate the effect of creatinine in the MELD formula, a time‐dependent Cox regression model was performed to develop novel remodeled MELD scores. One scoring tool, the Reweight MELD score, assigned a lower weight to creatinine, which is similar to the Updated MELD score. Another score (Del‐Cr‐MELD score) removed the creatinine component from the existing MELD score and reweighted the coefficient components of the other two variables (INR and bilirubin). We then developed the AKI‐MELD score as it related to its Cr~48hours~/Cr ratio to better associate it with CAKI. All scoring tools were compared using the area under the receiver operating characteristic curve (AUROC). The area under the curve provided the discriminative power of MELD score for the outcome of CAKI. A *P* value less than 0.05 was considered statistically significant.

Results {#hep41076-sec-0009}
=======

BASELINE CHARACTERISTICS OF THE STUDY POPULATION {#hep41076-sec-0010}
------------------------------------------------

The study population comprised 651 CAKI admitted to the ICU (median age, 57.46 ± 11.71 years; male patients, 418 \[67.3%\]) (Table [1](#hep41076-tbl-0001){ref-type="table-wrap"}). There were 75 (11.5%) patients who died in the 3‐month follow‐up. The most common ethnicity was Caucasian (442 \[71.2%\]). Detailed information is shown in Table [2](#hep41076-tbl-0002){ref-type="table-wrap"}.

###### 

CHARACTERISTICS OF 651 CRITICALLY ILL PATIENTS WITH CIRRHOSIS AND ACUTE KIDNEY INJURY

  Variable                             Mean ± SD or N (%)
  ------------------------------------ --------------------
  Age, year                            57.46 ± 11.71
  Sex,                                 
  Male patients, number (%)            418 (67.3%)
  Female patients, number (%)          203 (32.7%)
  Ethnicity                            
  Caucasians, number (%)               442 (71.2%)
  African Americans, number (%)        46 (7.4%)
  Other (%)                            133 (21.4%)
  Cirrhosis                            
  Alcoholic cirrhosis, number (%)      348 (56.0%)
  Biliary cirrhosis, number (%)        12 (1.9%)
  Nonalcoholic cirrhosis, number (%)   261 (42.0%)
  MELD                                 24.24 ± 10.33
  Reweight‐MELD                        0.60 ± 0.37
  Del‐Cr‐MELD                          0.57 ± 0.37
  AKI‐MELD                             0.58 ± 0.51
  MELD components                      
  Bilirubin, mg/dL                     8.31 ± 10.48
  Creatinine, mg/dL                    2.25 ± 1.74
  48‐hour creatinine, mg/dL            2.14 ± 1.66
  Cr~48hours~/Cr                       1.03 ± 0.45
  INR                                  2.12 ± 2.74
  Log~e~ MELD components               
  Bilirubin, mg/dL                     1.35 ± 1.30
  Creatinine, mg/dL                    0.58 ± 0.66
  48‐hour creatinine, mg/dL            0.53 ± 0.66
  Cr~48hours~/Cr                       −0.05 ± 0.40
  INR                                  0.64 ± 0.39

###### 

CHARACTERISTICS OF 651 CRITICALLY ILL PATIENTS WITH CIRRHOSIS AND ACUTE KIDNEY INJURY, STRATIFIED BY SURVIVAL

  -----------------------------------------------------------------------------------------
  Variable                             Survivors\            Nonsurvivors\      *P* Value
                                       (n = 277)             (n = 374)          
  ------------------------------------ --------------------- ------------------ -----------
  Age, year                            55.96 ±10.63          58.45 ±12.28       0.009

  Sex                                                                           0.930

  Male patients, number (%)            167 (67.6%)           251 (67.1%)        

  Female patients, number (%)          80 (32.4%)            123 (32.9%)        

  Ethnicity                                                                     0.050

  Caucasians, number (%)               183 (74.1%)           259 (69.3%)        

  African Americans, number (%)        25 (10.1%)            21 (5.6%)          

  Other (%)                            39 (15.8%)            94 (25.1%)         

  Cirrhosis                                                                     0.843

  Alcoholic cirrhosis, number (%)      141 (57.1%)           207 (55.3%)        

  Biliary cirrhosis, number (%)        4 (1.6%)              8 (2.1%)           

  Nonalcoholic cirrhosis, number (%)   102 (41.3%)           159 (42.5%)        

  MELD                                 21.74 ± 9.07          25.9 ± 10.77       \<0.001

  Reweight‐MELD                        0.49 ± 0.32           0.67 ± 0.38        \<0.001

  Del‐Cr‐MELD                          0.47 ± 0.32           0.64 ± 0.38        \<0.001

  AKI‐MELD                             0.4 ± 0.49            0.69 ± 0.48        \<0.001

  MELD components                                                               

  Bilirubin, mg/dL                     6.03 ± 8.97           9.81 ± 11.12       \<0.001

  Creatinine, mg/dL                    2.17 ± 1.67           2.31 ± 1.78        0.316

  48‐hour creatinine, mg/dL            1.83 ± 1.34           2.35 ± 1.81        \<0.001

  Cr~48hours~/Cr                       0.95 ± 0.46           1.08 ± 0.44        \<0.001

  INR                                  1.81 ± 0.70           2.33 ± 3.47        0.021

  Log~e~ MELD components                                                        

  Bilirubin, mg/dL                     1.03 ± 1.21           1.56 ± 1.31        \<0.001

  Creatinine, mg/dL                    0.56 ± 0.64           0.60 ± 0.68        0.413

  48‐hour creatinine, mg/dL            0.41 ± 0.61           0.62 ± 0.68        \<0.001

  Cr~48hours~/Cr                       −0.15 ± 0.44          0.01 ± 0.36        \<0.001

  INR                                  0.54 ± 0.31           0.70 ± 0.42        \<0.001

  Laboratory parameters                                                         

  Glucose, mg/dL                       142.81 ± 85.51        127.76 ± 58.19     0.009

  Sodium, mEq/L                        134.13 ± 6.92         133.90 ± 7.33      0.696

  Potassium, mEq/L                     4.21 ± 0.91           4.42 ± 1.03        0.013

  PaO~2~, mmHg                         160.02 ± 123.11       123.42 ± 96.68     \<0.001

  PCO~2~, mmHg                         37.20 ± 9.27          37.43 ± 11.67      0.795

  FIO~2~                               55.60 ± 34.17         66.16 ± 32.32      \<0.001

  Lactate, mg/dL                       2.86 ± 2.14           3.72 ± 3.14        \<0.001

  Urine output, mL                     1,934.91 ± 2,414.36   994.5 ± 1,415.54   \<0.001
  -----------------------------------------------------------------------------------------

Abbreviations: FiO~2~, fraction of inspired oxygen; PaO~2~, partial pressure of arterial oxygen; PCO~2~, partial pressure of arterial carbon dioxide.

IS CREATININE RELATED TO A PERFECT PREDICTIVE PERFORMANCE IN CAKI? {#hep41076-sec-0011}
------------------------------------------------------------------

Univariate analysis was performed for bilirubin (HR, 1.293; 95% confidence interval \[CI\], 1.194‐1.401; *P* \< 0.001); Cr~48hours~/Cr (HR, 1.932; 95% CI, 1.514‐2.465; *P* \< 0.001); INR (HR, 2.054; 95% CI, 1.691‐2.494; *P* \< 0.001), and creatinine (HR, 1.104; 95% CI, 0.945‐1.290; *P,* 0.211) (Table [3](#hep41076-tbl-0003){ref-type="table-wrap"}).

###### 

UNIVARIATE AND MULTIVARIATE ANALYSIS OF ASSOCIATION BETWEEN Log~e~ MELD COMPONENTS AND 1‐YEAR MORTALITY IN CRITICALLY ILL PATIENTS WITH CIRRHOSIS AND ACUTE KIDNEY INJURY

  Log~e~ MELD components   Univariate Analysis                   
  ------------------------ --------------------- --------------- ---------
  Bilirubin, mg/dL         1.293                 (1.194‐1.401)   \<0.001
  Creatinine, mg/dL        1.104                 (0.945‐1.290)   0.211
  Cr~48hours~/Cr           1.932                 (1.514‐2.465)   \<0.001
  INR                      2.054                 (1.691‐2.494)   \<0.001

Creatinine at admission to the ICU was not associated with the mortality of CAKI in our study despite its high impact on the existing MELD formula. We therefore evaluated the role of creatinine in the MELD formula. We hypothesized that the remodeled MELD scores without creatinine or with a relatively lower weight of creatinine might have a better predictive performance. The Cox regression model was performed, and the final models were represented as follows: Reweight‐MELD: R = 0.250 × log~e~(creatinine \[mg/dL\]) + 0.584 × log~e~(bilirubin \[mg/dL\]) + 0.179 × log~e~(INR); Del‐Cr‐MELD: R = 0.249 × log~e~(bilirubin \[mg/dL\]) + 0.595 × log~e~(INR) (Table [4](#hep41076-tbl-0004){ref-type="table-wrap"}).

###### 

COMPARISON OF COEFFICIENTS OF MELD COMPONENTS IN MELD, REWEIGHT‐MELD, DEL‐CR‐MELD, AND AKI‐MELD FORMULAS

                          MELD    Reweight‐MELD   Del‐Cr‐MELD           AKI‐MELD                                 
  ----------------------- ------- --------------- --------------------- ---------- --------------------- ------- ---------------------
  Log~e~ bilirubin        0.378   0.250           1.285 (1.142‐1.445)   0.249      1.283 (1.140‐1.445)   0.225   1.252 (1.110‐1.412)
  Log~e~ INR              1.120   0.584           1.792 (1.380‐2.328)   0.595      1.813 (1.401‐2.345)   0.609   1.839 (1.416‐2.388)
  Log~e~ creatinine       0.957   0.179           1.196 (0.973‐1.471)   --         --                    --      --
  Log~e~ Cr~48hours~/Cr   --      --              --                    --         --                    0.562   1.754 (1.265‐2.432)

The performances of Reweight‐MELD score and Del‐Cr‐MELD score for predicting mortality were competitive with an AUROC of 0.675 and 0.678 at 30 days, 0.669 and 0.671 at 90 days, and 0.637 and 0.636 at 1 year, respectively. The MELD score had an AUROC of 0.639 at 30 days, 0.637 at 90 days, and 0.614 at 1 year (all *P* \< 0.05) (Table [5](#hep41076-tbl-0005){ref-type="table-wrap"}). With advanced critical illness, patients with increasing MELD score were found to have increased area under the curve gap of MELD score and other remodeling scoring (Reweight‐MELD score and Del‐Cr‐MELD score). Therefore, we considered that creatinine was too heavily weighted in the existing MELD formula for CAKI.

###### 

COMPARISON OF INDEX OF CONCORDANCE FOR MELD, REWEIGHT‐MELD, DEL‐CR‐MELD, AND AKI‐MELD

                     MELD    Reweight‐MELD   Del‐Cr‐MELD   AKI‐MELD
  ------------------ ------- --------------- ------------- ----------
  30‐day mortality                                         
  All                0.639   0.675           0.678         0.715
  MELD ≥10           0.648   0.688           0.689         0.723
  MELD ≥15           0.642   0.685           0.684         0.717
  MELD ≥20           0.617   0.678           0.677         0.709
  MELD ≥25           0.591   0.663           0.665         0.710
  90‐day mortality                                         
  All                0.637   0.669           0.671         0.704
  MELD ≥10           0.642   0.677           0.676         0.708
  MELD ≥15           0.631   0.672           0.671         0.701
  MELD ≥20           0.591   0.653           0.655         0.685
  MELD ≥25           0.581   0.650           0.652         0.688
  1‐year mortality                                         
  All                0.614   0.637           0.636         0.667
  MELD ≥10           0.621   0.646           0.643         0.672
  MELD ≥15           0.600   0.636           0.635         0.667
  MELD ≥20           0.573   0.629           0.630         0.662
  MELD ≥25           0.562   0.626           0.629         0.671

All *P* values \< 0.05 (versus AKI‐MELD).

AKI‐MELD: Cr~48hours~/Cr MAY BE A BETTER PREDICTOR THAN CREATININE WHEN MELD IS USED IN CAKI {#hep41076-sec-0012}
--------------------------------------------------------------------------------------------

The AKI‐MELD formula derived from the time‐dependent model was based on all the serial Cr~48hours~/Cr, bilirubin, and INR values in the Multiparameter Intelligent Monitoring in Intensive Care 3.0 database for the study cohort. The final model was represented as follows: R = 0.225 × log~e~(Cr~48hours~/Cr) + 0.609 × log~e~(bilirubin \[mg/dL\]) + 0.562 × log~e~(INR) (Table [4](#hep41076-tbl-0004){ref-type="table-wrap"}).

THE PERFORMANCE OF AKI‐MELD COMPARED WITH OTHER MELD SCORES {#hep41076-sec-0013}
-----------------------------------------------------------

Kaplan‐Meier curves were generated for time to event. All individuals were categorized into four groups by the AKI‐MELD level: Q1 (≤0.220), Q2 (0.220‐0.564), Q3 (0.564‐0.952), and Q4 (≥0.952). Increasing AKI‐MELD was progressively associated with an increased MELD of CAKI (Fig. [1](#hep41076-fig-0001){ref-type="fig"}).

![Kaplan‐Meier curves stratified by different risk levels of AKI‐MELD (*P* \< 0.05).](HEP4-1-748-g001){#hep41076-fig-0001}

Performance of AKI‐MELD score in predicting short‐term mortality in the internal cohort was competitive, with an AUROC of 0.720 (95% CI, 0.653‐0.762) at 30 days, 0.688 (95% CI, 0.630‐0.742) at 90 days, and 0.671 (95% CI, 0.612‐0.725) at 1 year. Compared to MELD score, MELD‐Na score, and Updated MELD score, AKI‐MELD score indicated a 6% to 15% improvement in discriminative capability (all *P* \< 0.001).

STRATIFIED ANALYSIS {#hep41076-sec-0014}
-------------------

In the stratified analysis, AKI‐MELD score for more critically ill candidates (with higher MELD scores) had a significantly higher predictive ability. As MELD score was considered to be a predictive tool for CAKI with MELD ≥25, the MELD score performance was undesirable, having an AUROC of 0.591 at 30 days, 0.581 at 90 days, and 0.562 at 1 year (Table [5](#hep41076-tbl-0005){ref-type="table-wrap"}; Fig. [2](#hep41076-fig-0002){ref-type="fig"}). These patients with high MELD scores may be overestimated, especially when they had a higher serum creatinine level along with lower bilirubin and/or INR.

![AUROC analysis of the prognostic efficiency of AKI‐MELD and other existing MELD models (MELD, MELD‐Na, and Updated MELD) to predict (A) 30‐day, (B) 90‐day, and (C) 1‐year mortality of CAKI (all *P* \< 0.05).](HEP4-1-748-g002){#hep41076-fig-0002}

PERFORMANCE OF AKI‐MELD IN PREDICTING MORTALITY: COMPARISON OF MELD, MELD‐Na, AND UPDATED MELD {#hep41076-sec-0015}
----------------------------------------------------------------------------------------------

A comparison between AKI‐MELD score and other MELD scoring systems (MELD‐Na score and Updated MELD score) was also completed to assess the discriminative power of this new scoring model. AKI‐MELD score was considered to be a reliable model in predicting all mortality (Fig. [3](#hep41076-fig-0003){ref-type="fig"}) (AUROC, 0.715 \[95% CI, 0.678‐0.750\] at 30 days, 0.704 \[95% CI, 0.666‐0.739\] at 90 days, and 0.667 \[95% CI, 0.629‐0.704\] at 1 year) compared with MELD‐Na (0.589 \[0.549‐0.628\] at 30 days, 0.603 \[95% CI, 0.563‐0.641\] at 90 days, and 0.573 \[95% CI, 0.533‐0.612\] at 1 year) and Updated MELD (0.666 \[95% CI, 0.628‐0.703\] at 30 days, 0.661 \[95% CI, 0.623‐0.699\] at 90 days, and 0.633 \[95% CI, 0.594‐0.671\] at 1 year) (Fig. [2](#hep41076-fig-0002){ref-type="fig"}; Table [6](#hep41076-tbl-0006){ref-type="table-wrap"}). The Updated MELD score with relatively lower creatinine weight was slightly superior to the other existing MELDs (MELD score and MELD‐Na score).

###### 

DIAGNOSTIC ACCURACY OF DIFFERENT PROGNOSTIC MODELS IN PREDICTING 1‐YEAR MORTALITY USING THE OPTIMAL CUT‐OFF POINT

  Prognostic models   Cutoff   AUROC   95% CI          Sensitivity   Specificity   Youden Index   Goodness‐of‐Fit (χ^2^)   df   *P*
  ------------------- -------- ------- --------------- ------------- ------------- -------------- ------------------------ ---- -------
  AKI‐MELD            0.75     0.667   (0.629‐0.704)   0.547         0.770         0.317          4.167                    8    0.842
  MELD                23.01    0.614   (0.575‐0.653)   0.666         0.601         0.267          12.379                   8    0.135
  MELD‐Na             32.70    0.573   (0.533‐0.612)   0.436         0.735         0.171          7.593                    8    0.474
  Updated‐MELD        4.95     0.633   (0.594‐0.671)   0.578         0.723         0.300          8.329                    8    0.402

![AUROC analysis of the prognostic efficiency of AKI‐MELD and other existing MELD models (MELD, MELD‐Na, and Updated MELD) to predict (A) 30‐day, (B) 90‐day, and (C) 1‐year mortality of CAKI with MELD ≥25 (all *P* \< 0.05).](HEP4-1-748-g003){#hep41076-fig-0003}

Discussion {#hep41076-sec-0016}
==========

AKI is a severe complication in critically ill patients with cirrhosis that occurs in a substantial proportion of the patients admitted with cirrhosis.[22](#hep41076-bib-0022){ref-type="ref"}, [23](#hep41076-bib-0023){ref-type="ref"} Severe hypoperfusion causes acute kidney failure/injury and impairment in the systemic arterial circulation, which can lead to marked splanchnic arterial vasodilatation and arterial hypotension.[3](#hep41076-bib-0003){ref-type="ref"}, [24](#hep41076-bib-0024){ref-type="ref"}, [25](#hep41076-bib-0025){ref-type="ref"} Subsequent studies have confirmed several other causes leading to acute impairment of kidney function, including bacterial infections, volume depletion, chronic kidney diseases, and administration of nephrotoxic agents.[26](#hep41076-bib-0026){ref-type="ref"} It has been unequivocally demonstrated that serum creatinine is associated with short‐ and long‐term mortality in patients with cirrhosis.[27](#hep41076-bib-0027){ref-type="ref"} MELD score was calculated based on the creatinine level at the time of ICU admission, while the definitions of AKI depended on changes in serum creatinine within 48 hours. We questioned which value and change of creatinine was more accurate for prognosis mortality.

In our observation database, HRs of creatinine and Cr~48hours~/Cr were 1.104 (95% CI, 0.945‐1.290; *P* = 0.211) and 1.932 (95% CI, 1.514‐2.465; *P* \< 0.001), respectively. While the relative weight of creatinine in the MELD formula was 0.390, the relative weights of Reweight‐MELD score and Del‐Cr‐MELD score were 0.177 and 0, respectively (Table [7](#hep41076-tbl-0007){ref-type="table-wrap"}). Reweight‐MELD score and Del‐Cr‐MELD score showed a limited improvement in discriminative capability, indicating that the predictive value of creatinine for CAKI should be re‐evaluated. Although the definition of AKI is debatable, the risk, injury, failure, loss, and end‐stage kidney disease classification and the Acute Kidney Injury Network criteria are based on the changes of creatinine. Loef et al.[28](#hep41076-bib-0028){ref-type="ref"} also revealed that changes in serum creatinine during the first postoperative week are related to short‐ and long‐term mortality. In a similar population, the patients with AKI had significantly increased mortality under a broad spectrum of conditions.[29](#hep41076-bib-0029){ref-type="ref"}, [30](#hep41076-bib-0030){ref-type="ref"} Furthermore, the severity of AKI is linked directly to mortality risk.[29](#hep41076-bib-0029){ref-type="ref"}, [30](#hep41076-bib-0030){ref-type="ref"}

###### 

COMPARISON OF RELATIVE WEIGHTS OF MELD COMPONENTS IN MELD, REWEIGHT‐MELD, DEL‐CR‐MELD, AND AKI‐MELD FORMULAS

  MELD Component          Coefficient   SD      Coefficient × SD   Relative Weight[a](#hep41076-note-0005){ref-type="fn"}
  ----------------------- ------------- ------- ------------------ --------------------------------------------------------
  MELD                                                             
  Log~e~ bilirubin        0.378         1.296   0.490              0.154[b](#hep41076-note-0006){ref-type="fn"}
  Log~e~ INR              1.120         0.386   1.452              0.456
  Log~e~ creatinine       0.957         0.662   1.24               0.390
  Column sum              --            --      3.182              1
  Reweight‐MELD                                                    
  Log~e~ bilirubin        0.250         1.296   0.324              0.247
  Log~e~ INR              0.584         0.386   0.757              0.577
  Log~e~ creatinine       0.179         0.662   0.232              0.177
  Column sum              --            --      1.313              1
  Del‐Cr‐MELD                                                      
  Log~e~ bilirubin        0.249         1.296   0.323              0.295
  Log~e~ INR              0.595         0.386   0.771              0.705
  Column sum              --            --      1.094              1
  AKI‐MELD                                                         
  Log~e~ bilirubin        0.225         1.296   0.292              0.161
  Log~e~ INR              0.609         0.386   0.789              0.436
  Log~e~ Cr~48hours~/Cr   0.562         0.401   0.728              0.402
  Column sum              --            --      1.809              1

Adjustment of coefficient × SD to a sum of 1.

0.490/3.182 = 0.154.

In the majority of patients, a transient rise in creatinine is the single manifestation of renal function impairment. Therefore, the change in creatinine within 48 hours was considered as a perfect variable for AKI. In accordance with other studies, we found that a substantial proportion of patients with cirrhosis with serum creatinine within the normal range had impaired renal function.[31](#hep41076-bib-0031){ref-type="ref"}, [32](#hep41076-bib-0032){ref-type="ref"} A remodeled model with the substitution of creatinine by Cr~48hours~/Cr may result in an improvement in its prognostic accuracy.

In our study, the novel specific prognostic score AKI‐MELD score was developed and consisted of bilirubin, INR, and Cr~48hours~/Cr. Compared to MELD score, the AUROC performance of AKI‐MELD score showed an improvement in discriminating survivors at each period. In the stratified analysis, the AUROC performance of MELD was undesirable (less than 0.60) for critically ill patients (MELD ≥25). CAKI with MELD ≥25 had transient increases in Cr (lower bilirubin and/or INR) and may have less severe liver synthetic dysfunction, but the mortality risk was overestimated based on MELD score.

This research is the first and largest study to generate a specific clinical risk prognostic model (AKI‐MELD score) for discriminating survivors from CAKI. However, the study has potential limitations. First, because this was a retrospective study from a single center, potential selection bias might exist. Second, although AKI‐MELD score showed a preferable discriminative performance for predicting mortality in this large‐scale database, the estimate of predictive ability of the AKI‐MELD equation was based on the same data from which it was derived. This could potentially lead to overfitting, and further multicenter studies are needed to verify its applicability in a broad spectrum database. Third, the classification of histology may have contributed to a stratified analysis; however, a liver biopsy was not completed for each candidate and detailed histology data were absent in our research. Fourth, ignoring technological advances and changes in medical practice may have produced a certain bias on the database over an 11‐year period.

In conclusion, the predictive value of creatinine for CAKI should be re‐evaluated. AKI‐MELD score provided an improvement over the existing MELD score and may provide an optimal scoring system for CAKI. Further research is needed to clarify the validity of the AKI‐MELD score.
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